retatrutide phase 2 results obesity nejm 2023 Trial of for Retatrutide Phase 2 NEJM Trial:

So while diet and exercise are important, so is addressing hormones, reducing stress, and prioritizing sleep

Fun fact: the FDA does not consider a medication commercially available if there is a shortage of that medication

Most patients manage it easily by staying hydrated, eating smaller portions, and not pushing past fullness

The adoption of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has skyrocketed over the past few years, ushering in a new era of weight management and type 2 diabetes mellitus (T2DM) care

Start with a half serving for at least a week

Most importantly, digital tools foster patient autonomy